Updated daily
# | PubMedId | Deleted | Publication |
---|---|---|---|
38663489 | 0 | Ferraresso F, Leung J, Kastrup CJ. RNA Therapeutics to Control Fibrinolysis: Review on Applications in Biology and Medicine. J Thromb Haemost. 2024 Apr 23:S1538-7836(24)00224-1. doi: 10.1016/j.jtha.2024.04.006. | |
38381848 | 0 | Strilchuk AW, Hur WS, Batty P, et al. Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia A. Sci Transl Med. 2024 Feb 21;16(735):eadh0027. doi: 10.1126/scitranslmed.adh0027. Epub 2024 Feb 21. | |
37061138 | 0 | Ali-Mohamad N, Cau MF, Zenova V, et al. Self-propelling thrombin powder enables hemostasis with no observable rebleeding or thrombosis over three days in a porcine model of upper gastrointestinal bleeding. Gastrointest Endosc. 2023 Apr 13:S0016-5107(23)00393-0. doi: 10.1016/j.gie.2023.04.007. | |
34958662 | 0 | Juang LJ, Hur WS, Silva LM, et al. Suppression of fibrin(ogen)-driven pathologies through controlled knockdown by lipid nanoparticle delivery of siRNA. Blood. 2021 Dec 27. pii: 483255. doi: 10.1182/blood.2021014559. | |
34941394 | 0 | Silva LM, Doyle AD, Greenwell-Wild T, et al. Fibrin is a critical regulator of neutrophil effector function at the oral mucosal barrier. Science. 2021 Dec 24;374(6575):eabl5450. doi: 10.1126/science.abl5450. Epub 2021 Dec 24. | |
34905618 | 0 | Hur WS, Paul DS, Bouck EG, et al. Hypofibrinogenemia with preserved hemostasis and protection from thrombosis in mice with a Fga truncation mutation. Blood. 2021 Dec 14. pii: 483059. doi: 10.1182/blood.2021012537. | |
33208779 | 0 | Chan KYT, Yong ASM, Wang X, et al. The adhesion of clots in wounds contributes to hemostasis and can be enhanced by coagulation factor XIII. Sci Rep. 2020 Nov 18;10(1):20116. doi: 10.1038/s41598-020-76782-z. | |
32685890 | 0 | Mazinani N, Strilchuk AW, Baylis JR, et al. Bleeding is increased in amyloid precursor protein knockout mouse. Res Pract Thromb Haemost. 2020 Jun 14;4(5):823-828. doi: 10.1002/rth2.12375. eCollection 2020 Jul. | |
32339233 | 0 | Juang LJ, Mazinani N, Novakowski SK, et al. Coagulation factor XII contributes to hemostasis when activated by soil in wounds. Blood Adv. 2020 Apr 28;4(8):1737-1745. doi: 10.1182/bloodadvances.2019000425. | |
31145837 | 0 | Baylis JR, Lee MM, St John AE, et al. Topical tranexamic acid inhibits fibrinolysis more effectively when formulated with self-propelling particles. J Thromb Haemost. 2019 Oct;17(10):1645-1654. doi: 10.1111/jth.14526. Epub 2019 Jun 26. | |
30762590 | 0 | Hur WS, Warner H, Machan L, et al. Coagulation factor XIII-A and activated FXIII-A decrease in some deep vein thrombosis patients following catheter-directed thrombolysis. Blood Coagul Fibrinolysis. 2019 Jun;30(4):176-180. doi: 10.1097/MBC.0000000000000797. | |
28186112 | 0 | Yeon JH, Mazinani N, Schlappi TS, et al. Localization of Short-Chain Polyphosphate Enhances its Ability to Clot Flowing Blood Plasma. Sci Rep. 2017 Feb 10;7:42119. doi: 10.1038/srep42119. | |
27207421 | 0 | Baylis JR, Chan KY, Kastrup CJ. Halting hemorrhage with self-propelling particles and local drug delivery. Thromb Res. 2016 May;141 Suppl 2:S36-9. doi: 10.1016/S0049-3848(16)30362-0. | |
27140446 | 0 | Chan KY, Zhao C, Siren EM, et al. Adhesion of Blood Clots Can Be Enhanced When Copolymerized with a Macromer That Is Crosslinked by Coagulation Factor XIIIa. Biomacromolecules. 2016 Jun 13;17(6):2248-52. doi: 10.1021/acs.biomac.6b00481. Epub 2016 May 17. | |
26359437 | 0 | Hur WS, Mazinani N, Lu XJ, et al. Coagulation factor XIIIa is inactivated by plasmin. Blood. 2015 Nov 12;126(20):2329-37. doi: 10.1182/blood-2015-07-650713. Epub 2015 Sep 10. | |
25975772 | 0 | Hun Yeon J, Chan KY, Wong TC, et al. A biochemical network can control formation of a synthetic material by sensing numerous specific stimuli. Sci Rep. 2015 May 15;5:10274. doi: 10.1038/srep10274. |